For informational purposes only.
Metformin Hydrochloride Tablet
Metbetic tablet
Metbetic tablet is prescribed for the treatment of type 2 diabetes mellitus.
Metbetic tablet Composition :-
Metformin Hydrochloride ................ 500mg
Metbetic Tablet Uses :-
Metbetic tablet is used in the treatment of type 2 diabetes mellitus. Metbetic tablet helps to control blood sugar level and prevents serious complications of diabetes.
By lowering or controlling blood sugar levels in this way, you can reduce your risk of serious complications of diabetes such as kidney damage, nerve problems, eye damage and loss of organs.
When Metbetic tablet is used along with a healthy diet and exercise, it helps a lot in controlling blood sugar.
Apart from this, Metbetic tablet is used to treat polycystic ovary syndrome (PCOS), a menstrual disorder in women.
Metbetic Tablet Dosage :-
Metbetic tablet is a prescription medicine. Take Metbetic tablet as directed by your doctor. Use Metbetic tablet exactly as directed by the doctor. Do not take a higher or lower dose than directed by your doctor.
Metbetic tablet should be taken during or after a meal. Never self-medicate or change the dosage without a doctor's advice. Do not take 2 or more doses at the same time.
Always try to take Metbetic tablet on regular schedule. Always take the tablet even if you feel well or your blood sugar level is under control. Do not stop taking without your doctor's advice. Otherwise, your blood sugar level may rise again. Do not stop taking Metformin hydrochloride tablet without asking your doctor. Because the treatment of diabetes is lifelong.
How Does Metbetic tablet Work :-
Metbetic tablet contains : Metformin Hydrochloride.
Metformin Hydrochloride :
Metformin hydrochloride is an antidiabetic medicine belonging to a class of drugs called biguanides.
Metformin delays the absorption of glucose from the intestines, by reducing the production of glucose in the liver. And thus metformin works by increasing the sensitivity of the body to insulin.
Thus Metbetic tablet works by controlling the level of sugar in the blood.
Metbetic Tablet Sideeffects :-
Low blood sugar (hypoglycemia),
Nausea,
Vomiting,
Change in taste,
Diarrhea,
Stomach ache,
Stomach enlargement,
Loss of appetite and many other side effects can occur.
Metbetic Tablet Price:-
MRP ₹ : 14.36 ( 10 tabs )
MRP ₹ : 14.36 ( 10 tabs )
Packing Information :-
Metbetic Tablet Marketed By :-
Cadila Pharmaceuticals Ltd
Cadila Pharmaceuticals Ltd
Metbetic Tablet Self life :-
Please see the expiry date/manufacture date printed on Metbetic tablet pack.
Please see the expiry date/manufacture date printed on Metbetic tablet pack.
Safety Advice :-
Pregnancy : Safe
Metbetic tablet is safe to use during pregnancy. Animal studies have shown no or no adverse effects on the developing baby.
Breastfeeding : Safe
Metbetic tablet is safe to use during breastfeeding. Limited human data suggests that Metbetic does not represent any risk to the baby.
Driving : Caution
Your ability to drive may be affected if your blood sugar is too high or low during treatment with Metbetic tablet. Do not drive if you have these symptoms.
Kidney : Caution
Metbetic tablet should be used with caution in patients with kidney disease. Dose adjustment of Metbetic tablet may be needed. Consult your doctor for this. Use of Metbetic tablet is generally not advised in patients with severe kidney disease. Regular monitoring of kidney function tests is advised while you are taking Metbetic tablet.
Liver : Caution
Metbetic tablet should be used with caution in patients with liver disease. Dose adjustment of Metbetic tablet may be needed. Consult your doctor for this. Low dose of Metbetic tablet is generally started in patients with mild liver disease and use of Metbetic tablet is not recommended in patients with severe liver disease.
Alcohol : Unsafe
It is unsafe to consume alcohol while taking Metbetic tablet. Therefore, do not consume alcohol after taking Metbetic tablet.
Classification :-
Therapeutic Class - Antidiabetic drugs, biguanides,
Information on this page was last updated on 24 September 2021